IFLI - Institute for Follicular Lymphoma Innovation is a venture capital firm. Based in Diamond Bar, California, United States. Known portfolio companies include LTZ Therapeutics, Enterome, Innate Pharma, Araris Biotech, Verismo Therapeutics and CIT Therapeutics, 7 companies in all.
Is IFLI - Institute for Follicular Lymphoma Innovation a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Who to pitch at IFLI - Institute for Follicular Lymphoma Innovation
IFLI - Institute for Follicular Lymphoma Innovation portfolio companies (7)
- LTZ Therapeutics
- Enterome
- Innate Pharma
- Araris Biotech
- Verismo Therapeutics
- CIT Therapeutics
- PeproMene Bio
Co-investors
Funds that share portfolio companies with IFLI - Institute for Follicular Lymphoma Innovation.
Similar funds
Showing 20 of 100
About IFLI - Institute for Follicular Lymphoma Innovation
The firm's listing covers sector Healthcare, and focus areas Biotech, Drug Discovery, Healthcare Operations and Immunotherapy; known deals cluster at Late-Stage, Seed and Series A.
Tracy Dooley MD (Venture Partner) is listed as the contact to pitch at IFLI - Institute for Follicular Lymphoma Innovation.
Across the known portfolio, 9 co-investors appear alongside IFLI - Institute for Follicular Lymphoma Innovation, including The Leukemia & Lymphoma Society’s Therapy Acceleration Program, K2 Venture Capital and BRV Capital Management.
Frequently asked questions
What is IFLI - Institute for Follicular Lymphoma Innovation?
IFLI - Institute for Follicular Lymphoma Innovation is a venture capital firm based in Diamond Bar, California, United States, with a known portfolio of 7 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does IFLI - Institute for Follicular Lymphoma Innovation invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Healthcare Operations and Immunotherapy. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does IFLI - Institute for Follicular Lymphoma Innovation invest at?
The known deals of IFLI - Institute for Follicular Lymphoma Innovation include Late-Stage, Seed and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at IFLI - Institute for Follicular Lymphoma Innovation?
One person at IFLI - Institute for Follicular Lymphoma Innovation is on file, listed as a contact for the firm, with their own profile page.
How do I contact IFLI - Institute for Follicular Lymphoma Innovation?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The one person attached to the firm has their own page, which shows whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal